Hereditary Spherocytosis and Pregnancy: A Case Report
Keywords:Anemia, Hemolytic/etiology, Hypertension, Portal/complications, Pregnancy Complications, Spherocytosis, Hereditary/complications
Even though it is a rare condition, hereditary spherocytosis (EH) is the main inherited cause of haemolytic anaemia and presents with a broad spectrum of symptoms. In the few reported cases of pregnancy and EH, maternal and foetal outcomes are controversial. Particularly, reports of pregnancies with EH associated with thrombosis or portal hypertension are scarce. We present a case of a woman who underwent splenectomy with EH and non-cirrhotic portal hypertension. Our patient presented polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) and plasminogen activator inhibit-1 that have a controversial impact on thrombotic risk. During pregnancy, the woman showed no signs of haemodynamical or cirrhosis deterioration. Concerning the foetus, late-onset foetal growth restriction was diagnosed but did not determine preterm delivery. Five weeks post-partum after an episode of acute abdominal pain, mesenteric venous thrombosis was diagnosed. In this case report, we describe our experience in managing pregnancy, labour and post-partum of a woman with EH, highlighting potential complications of this condition.
Andolfo I, Russo R, Gambale A, Iolascon A. New insights on hereditary erythrocyte membrane defects. Haematologica. 2016;101:1284-94. DOI: https://doi.org/10.3324/haematol.2016.142463
Bolton-Maggs P, Langer J, Iolascon A, Tittensor P, King M. Guidelines for the diagnosis and management of hereditary spherocytosis - 2011 update. Br J Haematol. 2011;156:37-49. DOI: https://doi.org/10.1111/j.1365-2141.2011.08921.x
Mohren M, Markmann I, Dworschak U, Franke A, Maas C, Mewes S, et al. Thromboembolic complications after splenectomy for hematologic diseases. Am J Hematol. 2004;76:143-7. DOI: https://doi.org/10.1002/ajh.20018
de’Angelis N, Abdalla S, Lizzi V, Esposito F, Genova P, Roy L, et al. Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy. Surgery. 2017;162:1219-30. DOI: https://doi.org/10.1016/j.surg.2017.07.016
Andrade F, Shukla A, Bureau C, Senzolo M, D’Alteroche L, Heurgué A, et al. Pregnancy in idiopathic non-cirrhotic portal hypertension: a multicentric study on maternal and fetal management and outcome. J Hepatol. 2018;69:1242-9. DOI: https://doi.org/10.1016/j.jhep.2018.08.007
Pajor A, Lehoczky D, Szakács Z. Pregnancy and hereditary spherocytosis. Report of 8 patients and a review. Arch Gynecol Obstet. 1993;253:37-41. DOI: https://doi.org/10.1007/BF02770632
Maberry MC, Mason RA, Cunningham FG, Pritchard JA. Pregnancy complicated by hereditary spherocytosis. Obstet Gynecol. 1992;79:735-8.
Gershovitz M, Sergienko R, Friedler J, Wiznitzer A, Zlotnik A, Sheiner E. Pregnancy outcome in women following splenectomy. J Womens Health. 2011;20:1233-7. DOI: https://doi.org/10.1089/jwh.2011.2760
Khadke B, Prasad M, Gupta AS. A case of pregnancy with hereditary spherocytosis. 2018. [cited 2021 Jan 25]. Available from: http://www.jpgo.org/2018/12/a-case-of-pregnancy-with-hereditary.html.
Aggarwal N, Negi N, Aggarwal A, Bodh V, Dhiman R. Pregnancy with portal hypertension. J Clin Exp Hepatol. 2014;4:163-71. DOI: https://doi.org/10.1016/j.jceh.2014.05.014
Guan X, Huang L, Li L. Acute mesenteric venous thrombosis in a pregnant woman at 35 weeks of gestation: a case report and review of the literature. BMC Pregnancy Childbirth. 2018;18:487. DOI: https://doi.org/10.1186/s12884-018-2126-1
Miranda-Vilela AL. Role of polymorphisms in Factor V (FV Leiden), prothrombin, Plasminogen Activator Inhibitor Type-1 (PAI-1), Methylenetetrahydrofolate Reductase (MTHFR) and cystathionine. Mini-Rev Med Chem. 2012;12:997-1006. DOI: https://doi.org/10.2174/138955712802762338
Scifres C, Macones G. The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction? Am J Obstet Gynecol. 2008;199:344.e1-7. DOI: https://doi.org/10.1016/j.ajog.2008.04.051
Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies. Pathophysiol Haemost Thromb. 2002;32:51-8. DOI: https://doi.org/10.1159/000065076
How to Cite
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.